health Genetic Variants May Explain Why GLP-1 Drugs Fail for Some Patients
New research suggests specific genetic variations in the PAM gene could be the reason why GLP-1 medications like Ozempic are ineffective for approximately 10% of individuals with type 2 diabetes.
